课题基金 / 基金详情

Testing the efficacy of a strengths-based curriculum to reduce risk for future sexual violence perpetration among middle school boys

Testing the efficacy of a strengths-based curriculum to reduce risk for future sexual violence perpetration among middle school boys
测试基于优势的课程降低中学生未来性暴力风险的有效性
批准号:
9281241
负责人:
Leah Wentworth
金额:
$45.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2020-09-29

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Sexual violence is a widespread public health problem, with as many as 40% of women and 23% of men experiencing forced sexual contact at some point in their lives.1 The research and practice communities have expanded efforts related to understanding and preventing perpetration of sexual violence, rather than focusing exclusively on preventing sexual violence victimization. The CDC has identified a number of shared risk factors (such as exposure to relationship and family violence, low familial cohesion, and association with at-risk peers) that are connected with multiple forms of violence, including sexual violence. Using a matched pair control design, this study will evaluate the efficacy of a strengths-based curriculum, the Council for Boys and Young Men, to reduce risk for future sexual violence perpetration with middle school-aged boys (ages 12-14). We will collect baseline data at enrollment, and post- intervention data immediately after the course, then at 6 and 12 months after training. We will measure several outcomes linked to sexual assault perpetration, including bystander behavior, attitudes related to gender roles and acceptance of sexual violence, interpersonal relations, and youth-adult connectedness. Factors that impact implementation will also be assessed in order to examine the extent to which fidelity and quality influence participants' outcomes. The results of this study will inform future Rape Prevention and Education (RPE) program activities and expand the understanding of upstream sexual violence prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    肖勤
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: